Nelarabine Patent Expiration
Nelarabine is used for treating T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma that have not responded to or relapsed after two chemotherapy regimens. It was first introduced by Sandoz Inc
Nelarabine Patents
Given below is the list of patents protecting Nelarabine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arranon | US5424295 | 9-β-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine |
Jun 13, 2017
(Expired) | Sandoz |
| Arranon | US5492897 | Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives |
Feb 20, 2013
(Expired) | Sandoz |
| Arranon | US5747472 | Therapeutic methods for using ARA-G derivatives |
Feb 20, 2013
(Expired) | Sandoz |
| Arranon | US5821236 | Tumor treatment with arabinofuranosyl purine derivatives |
Feb 20, 2013
(Expired) | Sandoz |
Nelarabine's Family Patents
Explore Our Curated Drug Screens
Nelarabine Generic API Manufacturers
Several generic applications have been filed for Nelarabine. The first generic version for Nelarabine was by Zydus Pharmaceuticals Usa Inc and was approved on Nov 17, 2021. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Sep 13, 2024.
Given below is the list of companies who have filed for Nelarabine generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Aug 1, 2024 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Apr 4, 2023 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Dec 23, 2022 |
4. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 3, 2024 |
5. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jan 10, 2023 |
6. MSN
Msn Laboratories Private Ltd has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Sep 13, 2024 |
Manufacturing Plant Locations New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||
| United States |
| |||||||||||||||||||||
7. NEXUS
Nexus Pharmaceuticals Llc has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Nexus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Jun 2, 2023 |
Manufacturing Plant Locations New
Nexus's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Nexus as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||||||||
8. SHORLA
Shorla Pharma Ltd has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Shorla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Mar 3, 2023 |
9. XGEN PHARMS
Xgen Pharmaceuticals Djb Inc has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Xgen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Sep 5, 2024 |
10. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Nelarabine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG/50ML (5MG/ML) | injectable | Prescription | INTRAVENOUS | AP | Nov 17, 2021 |